Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myelodysplastic Syndromes × regorafenib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 25 Neoplasms 3 Neoplasm Metastasis 3 Gastrointestinal Stromal Tumors 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Gallbladder Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bile Duct Neoplasms 2 Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer) 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Rhabdomyosarcoma 1 Renal Insufficiency 1 Physician Education 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Noonan Syndrome 6 1 Metastatic Pancreatic Adenocarcinoma 1 Melanoma 1 Liver Neoplasms 1 Liposarcoma 1 Insulinoma 1 Glucagonoma 1

Interventions

fludarabine phosphate 76 Cyclophosphamide 70 Azacitidine 53 Whole-Body Irradiation 51 fludarabine 49 Mycophenolic Acid 46 Busulfan 46 Tacrolimus 42 Melphalan 36 Antilymphocyte Serum 34 Peripheral Blood Stem Cell Transplantation 33 Filgrastim 31 Cytarabine 31 Decitabine 30 Cyclosporine 27 Granulocyte Colony-Stimulating Factor 26 Methotrexate 25 thymoglobulin 21 Thiotepa 20 Cord Blood Stem Cell Transplantation 18 Clofarabine 18 Rituximab 15 Stem Cell Transplantation 14 Sirolimus 13 Lenalidomide 11 Etoposide 11 Alemtuzumab 11 venetoclax 9 Radiotherapy 9 sargramostim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡